Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Plunkett Matthew
Relationship:   Officer
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   563,709    

Indirect Shares

   0      
Direct Value   $4,783,249    

Indirect Value

   $0      
Total Shares   563,709      
Total Value   $4,783,249      


Cti Biopharma Corporation $4,783,249 Nkarta, Inc. $0 Cti Biopharma Corporation $4,783,249 Nkarta, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Chief Business Of... 2016-03-21 526,210 2012-10-16 0    Premium*  
            Nkarta, Inc. NKTX Officer 2020-07-09 37,499 0    Premium*  
* Premium Members only  

Records found :    38         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2012-10-16 4 A $0.00 $0 D/D 100,000 100,000 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2013-03-21 4 A $0.00 $0 D/D 296,705 396,705 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-01-30 4 A $0.00 $0 D/D 394,199 790,904 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-01-08 4 A $0.00 $0 D/D 477,255 871,223 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-09-21 4 A $0.00 $0 D/D 151,739 800,953 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-05-05 4 AS $2.93 $35,497 D/D (12,000) 608,904 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-06-04 4 AS $2.97 $36,256 D/D (12,000) 596,904 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-07-07 4 AS $2.82 $34,699 D/D (12,000) 584,904 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-08-04 4 AS $2.45 $29,722 D/D (12,000) 572,904 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-09-04 4 AS $2.47 $67,617 D/D (27,301) 545,603 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-09-22 4 AS $2.49 $133,560 D/D (51,817) 493,786 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-09-23 4 AS $2.50 $131,358 D/D (51,818) 441,968 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-10-06 4 AS $2.38 $28,733 D/D (12,000) 429,968 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-11-04 4 AS $2.37 $28,665 D/D (12,000) 417,968 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2014-12-04 4 AS $2.22 $26,808 D/D (12,000) 405,968 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-01-05 4 AS $2.34 $28,365 D/D (12,000) 393,968 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-02-04 4 AS $2.20 $26,651 D/D (12,000) 859,223 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-03-04 4 AS $2.39 $28,939 D/D (12,000) 847,223 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-03-23 4 AS $1.95 $116,029 D/D (59,130) 728,309 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-04-06 4 AS $1.86 $31,182 D/D (16,569) 711,740 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-05-04 4 AS $1.85 $18,553 D/D (10,000) 701,740 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-06-04 4 AS $2.05 $20,613 D/D (10,000) 691,740 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-07-06 4 AS $1.92 $19,493 D/D (10,000) 681,740 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-08-04 4 AS $1.84 $18,426 D/D (10,000) 671,740 0 -
CTIC Cti Biopharma Corporation EVP, Corporate Development   •       –      –    2015-09-04 4 AS $1.53 $15,355 D/D (10,000) 649,214 0 -
  38  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us